Skip to main content
. 2021 Nov 22;21:1258. doi: 10.1186/s12885-021-08928-9

Fig. 5.

Fig. 5

Construction and evaluation for ARGs signature model. (A-D) The risk score distribution, survival status and gene expression profiles in TCGA cohort (A) and GEO validation cohort (C). K-M survival curve of the ARGs signature for patients’ overall survival in the TCGA cohort (B) and GEO validation cohort (D). (E-F) Univariate Cox analysis of ARGs signature and clinical parameters in TCGA cohort (E) and GEO validation cohort (F)